MDM2 SNP309 and TP53 SNPArg72Pro Polymorphisms in Myelodysplastic Syndrome.

被引：0
|
作者：
Machado Neto, Joao Agostinho [1 ]
Traina, Fabiola [1 ]
Campos, Paula Melo [1 ]
Andreoli, Marilisia [1 ]
Metze, Irene Lorand [1 ]
Costa, Fernando Ferreira [1 ]
Saad, Sara T. O. [1 ]
机构：
[1] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
MDM2; p53; myelodysplasia; polymorphisms;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：693 / 694
页数：2
相关论文
共 50 条
  • [1] Tp53 codon 72 and MDM2 SNP309 polymorphisms in pancreatic cancer
    Hori, Yasuki
    Miyabe, Katsuyuki
    Yoshida, Michihiro
    Nakazawa, Takahiro
    Hayashi, Kazuki
    Naitoh, Itaru
    Shimizu, Shuya
    Kondo, Hiromu
    Nishi, Yuji
    Umemura, Shuichiro
    Ohara, Hirotaka
    Joh, Takashi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 213 - 214
  • [2] Lack of association between MDM2 SNP309 and TP53 Arg72Pro polymorphisms with clinical outcomes in myelodysplastic syndrome
    Machado-Neto, J. A.
    Traina, F.
    De Melo Campos, P.
    Andreoli-Risso, M. F.
    Costa, F. F.
    Olalla Saad, S. T.
    NEOPLASMA, 2012, 59 (05) : 530 - 535
  • [3] Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer
    Yoneda, Tomoko
    Kuboyama, Ayumi
    Kato, Kiyoko
    Ohgami, Tatsuhiro
    Okamoto, Kanako
    Saito, Toshiaki
    Wake, Norio
    ONCOLOGY REPORTS, 2013, 30 (01) : 25 - 34
  • [4] Investigation of the Effect of MDM2 SNP309 and TP53 Arg72Pro Polymorphisms on the Age of Onset of Cutaneous Melanoma
    Cotignola, Javier
    Chou, Joanne F.
    Roy, Pampa
    Mitra, Nandita
    Busam, Klaus
    Halpern, Allan C.
    Orlow, Irene
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (05) : 1471 - 1478
  • [5] Assessment of TP53 Polymorphisms and MDM2 SNP309 in Premenopausal Breast Cancer Risk
    Samuel, Nardin
    Id Said, Badr
    Guha, Tanya
    Novokmet, Ana
    Li, Weili
    Silwal-Pandit, Laxmi
    Borrsen-Dale, Anne-Lise
    Langerod, Anita
    Hudson, Thomas J.
    Malkin, David
    HUMAN MUTATION, 2017, 38 (03) : 265 - 268
  • [6] TP53 Arg 72Pro and MDM2 SNP309 Polymorphisms and Colorectal Cancer Risk: A West Algerian Population Study
    Abderrahmane, Rym
    Louhibi, Lotfi
    Moghtit, Fatima Zohra
    Boubekeur, Amina
    Benseddik, Khedidja
    Boudjema, Abdellah
    Benrrahal, Fouzia
    Aberkane, Meriem
    Fodil, Mostefa
    Saidi-Mehtar, Nadhira
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (03) : 629 - 635
  • [7] Effect of TP53 Arg72Pro and MDM2 SNP309 Polymorphisms on the Risk of High-Grade Osteosarcoma Development and Survival
    Toffoli, Giuseppe
    Biason, Paola
    Russo, Antonio
    De Mattia, Elena
    Cecchin, Erika
    Hattinger, Claudia Maria
    Pasello, Michela
    Alberghini, Marco
    Ferrari, Cristina
    Scotlandi, Katia
    Picci, Piero
    Serra, Massimo
    CLINICAL CANCER RESEARCH, 2009, 15 (10) : 3550 - 3556
  • [8] SNP309 in MDM2 associates to mutations in TP53 and aggressive bladder cancer
    Sanchez-Carbayo, M
    Erill, N
    Colomer, A
    Puig, X
    Levine, AJ
    Cordon-Cardo, C
    JOURNAL OF UROLOGY, 2006, 175 (04): : 199 - 199
  • [9] Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
    Hori, Yasuki
    Miyabe, Katsuyuki
    Yoshida, Michihiro
    Nakazawa, Takahiro
    Hayashi, Kazuki
    Naitoh, Itaru
    Shimizu, Shuya
    Kondo, Hiromu
    Nishi, Yuji
    Umemura, Shuichiro
    Kato, Akihisa
    Ohara, Hirotaka
    Inagaki, Hiroshi
    Joh, Takashi
    PLOS ONE, 2015, 10 (03):
  • [10] Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
    Hori, Yasuki
    Miyabe, Katsuyuki
    Yoshida, Michihiro
    Nakazawa, Takahiro
    Hayashi, Kazuki
    Naitoh, Itaru
    Shimizu, Shuya
    Kondo, Hiromu
    Nishi, Yuji
    Umemura, Shuichiro
    Kato, Akihisa
    Joh, Takashi
    GASTROENTEROLOGY, 2015, 148 (04) : S392 - S392
12345